Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ovarian cancer screening.

Literature DB >> 15313987

Ovarian cancer screening.

Usha Menon¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2004 PMID： 15313987 PMCID： PMC509040 DOI： 10.1503/cmaj.1031298

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

12 in total

1. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

Authors: S Sato; Y Yokoyama; T Sakamoto; M Futagami; Y Saito
Journal: Cancer Date: 2000-08-01 Impact factor: 6.860

2. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

Authors: J R van Nagell; P D DePriest; M B Reedy; H H Gallion; F R Ueland; E J Pavlik; R J Kryscio
Journal: Gynecol Oncol Date: 2000-06 Impact factor: 5.482

3. Screening for ovarian cancer: recommendation statement.

Authors:
Journal: Ann Fam Med Date: 2004 May-Jun Impact factor: 5.166

4. Small cystic pelvic masses in older women: is surgical removal necessary?

Authors: L D Roman
Journal: Gynecol Oncol Date: 1998-04 Impact factor: 5.482

5. Screening for ovarian cancer: a pilot randomised controlled trial.

Authors: I J Jacobs; S J Skates; N MacDonald; U Menon; A N Rosenthal; A P Davies; R Woolas; A R Jeyarajah; K Sibley; D G Lowe; D H Oram
Journal: Lancet Date: 1999-04-10 Impact factor: 79.321

6. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors: M A Hasson; R M Fagerstrom; D C Kahane; J H Walsh; M H Myers; C Caughman; B Wenzel; J C Haralson; L M Flickinger; L M Turner
Journal: Control Clin Trials Date: 2000-12

Review 7. Screening for ovarian cancer.

Authors: Sara Lewis; Usha Menon
Journal: Expert Rev Anticancer Ther Date: 2003-02 Impact factor: 4.512

8. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

Authors: Steven J Skates; Usha Menon; Nicola MacDonald; Adam N Rosenthal; David H Oram; Robert C Knapp; Ian J Jacobs
Journal: J Clin Oncol Date: 2003-05-15 Impact factor: 44.544

Review 9. The use of mathematical models to evaluate pelvic masses; can they beat an expert operator?

Authors: Dirk Timmerman
Journal: Best Pract Res Clin Obstet Gynaecol Date: 2004-02 Impact factor: 5.237

Review 10. Use of morphology to characterize and manage common adnexal masses.

Authors: Lil Valentin
Journal: Best Pract Res Clin Obstet Gynaecol Date: 2004-02 Impact factor: 5.237

7 in total

Review 1. Protein biomarkers of ovarian cancer: the forest and the trees.

Authors: Brian M Nolen; Anna E Lokshin
Journal: Future Oncol Date: 2012-01 Impact factor: 3.404

2. Ovarian cancer screening.

Authors: David M Allen
Journal: CMAJ Date: 2005-02-15 Impact factor: 8.262

3. Ovarian cancer screening.

Authors: Erica L Eason
Journal: CMAJ Date: 2005-02-15 Impact factor: 8.262

Review 4. Biomarker testing for ovarian cancer: clinical utility of multiplex assays.

Authors: Brian M Nolen; Anna E Lokshin
Journal: Mol Diagn Ther Date: 2013-06 Impact factor: 4.074

5. Identification of O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer.

Authors: Alan Kang-Wai Mu; Boon-Kiong Lim; Onn Haji Hashim; Adawiyah Suriza Shuib
Journal: Int J Mol Sci Date: 2013-04-11 Impact factor: 5.923

6. Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.

Authors: Victoria Yavelsky; Sarit Rohkin; Ruthy Shaco-Levy; Alina Tzikinovsky; Tamar Amir; Hila Kohn; Berta Delgado; Alex Rabinovich; Benjamin Piura; Gerald Chan; Gavreel Kalantarov; Ilya Trakht; Leslie Lobel
Journal: BMC Cancer Date: 2008-08-24 Impact factor: 4.430

7. No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.

Authors: B B J Hermsen; R I Olivier; R H M Verheijen; M van Beurden; J A de Hullu; L F Massuger; C W Burger; C T Brekelmans; M J Mourits; G H de Bock; K N Gaarenstroom; H H van Boven; T M Mooij; M A Rookus
Journal: Br J Cancer Date: 2007-04-10 Impact factor: 7.640

7 in total